1. Home
  2. SXI vs DYN Comparison

SXI vs DYN Comparison

Compare SXI & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Standex International Corporation

SXI

Standex International Corporation

N/A

Current Price

$220.50

Market Cap

3.3B

Sector

Industrials

ML Signal

N/A

DYN

Dyne Therapeutics Inc.

N/A

Current Price

$16.14

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SXI
DYN
Founded
1955
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.8B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
SXI
DYN
Price
$220.50
$16.14
Analyst Decision
Buy
Strong Buy
Analyst Count
6
17
Target Price
★ $332.40
$34.33
AVG Volume (30 Days)
159.0K
★ 2.2M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 0.66%
N/A
EPS Growth
★ 86.85
N/A
EPS
★ 1.98
N/A
Revenue
★ $604,535,000.00
N/A
Revenue This Year
$8.57
N/A
Revenue Next Year
$10.59
N/A
P/E Ratio
$110.62
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$216.57
$14.00
52 Week High
$363.89
$27.31

Technical Indicators

Market Signals
Indicator
SXI
DYN
Relative Strength Index (RSI) 32.70 41.96
Support Level N/A $14.43
Resistance Level $269.42 $19.48
Average True Range (ATR) 11.55 0.93
MACD -0.98 -0.17
Stochastic Oscillator 0.46 8.54

Price Performance

Historical Comparison
SXI
DYN

About SXI Standex International Corporation

Standex International Corp is a diversified industrial manufacturer with multiple products and services that are used in diverse commercial and industrial markets. The Company operates in four broad business segments: Electronics, Aerospace & Defense (A&D), Scientific, and Engraving & Hydraulics. The Electronics segment generates maximum revenue and is engaged in manufacturing and selling electronic components for applications throughout the end-user market spectrum. The Company has operations in the United States, Europe, Canada, Japan, Singapore, Mexico, Turkey, India, and China. The Company generates maximum revenue from the United States.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: